We thank the College of Physical Sciences, University of Aberdeen, for provision of infrastructure and facilities in the Marine Biodiscovery Centre. We acknowledge the receipt of funding from the European Union's Seventh Programme for Research, Technological Development and Demonstration under Grant Agreement No. 312184 (PharmaSea). MR thanks School of Science and Sport, University of the West of Scotland for providing the open-access fees required for the publication. ; Peer reviewed ; Publisher PDF
This work was funded by The Scottish Government Rural and Environment Science and Analytical Services Division (RESAS), Scotland, United Kingdom and the Biotechnology and Biological Sciences Research Council (BBSRC; East-Bio Doctoral Training Partnership), United Kingdom. The funders had no role in the design of the study, the analysis and interpretation of the data, or the publication process. The authors wish to thank Prof. John Hayes, University of Dundee, for the NQO1-luciferase construct and Prof. Gary Felsenfeld, NIH, Bethesda for the plasmid pJC13-1. ; Peer reviewed ; Postprint
Funding This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement ID: GA 721421 H2020-MSCA-ITN-2016. Declaration of competing interest MJ is founder of, has shares in, and consultant to GyreOx Ltd, a company that uses marine genetic resources from areas within national jurisdiction to develop potential drug molecules. Acknowledgements Many thanks to Arianna Broggiato and Abbe Brown for helpful discussions and comments on the manuscript. Thanks also to the Marie Curie H2020 fund for supporting this research. ; Peer reviewed ; Publisher PDF
Acknowledgements The authors also gratefully acknowledge financial support from the South African Medical Research Council (MRC) with funds received from the South African National Department of Health and the UK Government's Newton Fund (R. A. D., RL. M. G., K. C.), the UK Engineering and Physical Sciences Research Council EQATA (R. J. M. G.), the UK Global Challenge Research Fund (R. J. M. G., R. A. D.), the University of Cape Town (K. C.) and the South African Research Chairs Initiative of the Department of Science and Innovation, administered through the South African National Research Foundation (NRF) to K. C. (UID: 64767) and R. A. D. (UID: 87583). C. S. A. acknowledges financial support for SARS-CoV-2/Covid-19 research from UKMRC (CVG-1725-2020) and UKRI-DHSC (MR/Vo28464/1). The authors acknowledge Bronwyn Tweedie of the Rhodes University Print Services Unit who provided the graphics for Fig. 1 and thank Gordon Cragg for his insightful comments and encouragement during the preparation of this manuscript. ; Peer reviewed ; Publisher PDF
ACKNOWLEDGMENTS This project was funded by the Government of Kuwait (to F.N.A.) and the European Union's Seventh Framework Programme under grant agreement 245268 (ISEFOR; to L.B. and S.W.). Further support came from the SwissBOL project, financed by the Swiss Federal Office for the Environment (grant holder L.B.) and the Sciex–Scientific Exchange Programme NMS.CH (to L.L. and L.B.). ; Peer reviewed ; Publisher PDF
Ten bromotyrosine alkaloids were isolated and characterised from the marine sponge Aplysinella rhax (de Laubenfels 1954) collected from the Fiji Islands, which included one new bromotyrosine analogue, psammaplin P and two other analogues, psammaplin O and 3-bromo-2-hydroxy-5-(methoxycarbonyl)benzoic acid, which have not been previously reported from natural sources. HR-ESI-MS, 1D and 2D NMR spectroscopic methods were used in the elucidation of the compounds. Bisaprasin, a biphenylic dimer of psammaplin A, showed moderate activity with IC at 19±5 and 29±6 μM against Trypanzoma cruzi Tulahuen C4, and the lethal human malaria species Plasmodium falciparum clone 3D7, respectively, while psammaplins A and D exhibited low activity against both parasites. This is the first report of the antimalarial and antitrypanosomal activity of the psammaplin-type compounds. Additionally, the biosynthesis hypotheses of three natural products were proposed. ; E.O.and J.T. wish to thank Mr. Russell Gray of Marine Biodiscovery Centre, Aberdeen and Jesús Martín of Fundación Medina for NM R and mass spectrometry analysis, respectively.This work was partially sup-ported by the European Union Erasmus+Programme providing a mobility grant for E.O.to Granada,Spain.J.T. wishes to thank the resource owners of the districtof Wainunu, Bua,Fiji Islands,for the marine sponge used in this study. M.J. wishes to thank the EU Seventh Framework Programme Project Pharma Sea (grant agreement No. 312184 )for financial support and F.R wishes to thank Fundación MEDINA,Granada,Spain,for financia lsupport
ACKNOWLEDGMENTS This project was funded by the Kuwait Government (to F.N.A.), the European Union's Seventh Framework Programme under grant agreement no. 245268 (ISEFOR; to L.B. and S.W.). Further support came from the SwissBOL project, financed by the Swiss Federal Office for the Environment (grant holder, L.B.) and the Sciex–Scientific Exchange Programme NMS.CH (to L.B. and L.L.). ; Peer reviewed ; Publisher PDF
Open Access via Wiley publishing agreement Funding Information European Union Erasmus+ Programme EU Seventh Framework Programme Project PharmaSea. Grant Number: 312184 Fundación MEDINA, Granada, Spain ; Peer reviewed ; Publisher PDF
Acknowledgments This project was funded by the Government of Kuwait (to FA) and the European Union Seventh Framework Programme under grant agreement 245268 (ISEFOR; to LB and SW). Further support came from the SwissBOL project, financed by the Swiss Federal Office for the Environment (grant holder LB) and the Sciex–Scientific Exchange Programme (http://nms.ch/) (NMS.CH; to LL and LB). LL is indebted to the Ministry of Education, Science, Research and Sport of the Slovak Republic for financial support in the frame of the project "VEGA 1/0061/16" and "VEGA 1/0046/16". Funding This project was funded by the Government of Kuwait (to FA) and the European Union Seventh Framework Programme under grant agreement 245268 (ISEFOR; to LB and SW). Further support came from the SwissBOL project, financed by the Swiss Federal Office for the Environment (grant holder LB) and the Sciex–Scientific Exchange Programme NMS.CH (to LL and LB). LL is indebted to the Ministry of Education, Science, Research and Sport of the Slovak Republic for financial support in the frame of the project "VEGA 1/0061/16." ; Peer reviewed ; Publisher PDF
Acknowledgments The research leading to these results received funding from the following FEDER cofounded-grants. From CDTI and Technological Funds, supported by the Ministerio de Economía y Competitividad, AGL2012-40185-CO2-01, AGL2014-58210-R, and the Consellería de Cultura, Educación e Ordenación Universitaria, GRC2013-016, and through the Axencia Galega de Innovación, Spain, ITC-20133020 SINTOX. From CDTI under ISIP Programme, Spain, IDI-20130304 APTAFOOD. From the European Union's Seventh Framework Programme managed by REA—Research Executive Agency (FP7/2007-2013) under grant agreement 312184 PHARMASEA. ; Peer reviewed ; Publisher PDF
cknowledgements The research leading to these results has received funding from the following FEDER cofounded-grants. From CDTI and Technological Funds, supported by Ministerio de Economía y Competitividad, AGL2012-40185-CO2-01, AGL2014-58210-R, and Consellería de Cultura, Educación e OrdenaciónUniversitaria, GRC2013-016, and through AxenciaGalega de Innovación, Spain, ITC-20133020 SINTOX. From CDTI under ISIP Programme, Spain, IDI-20130304 APTAFOOD. From the European Union's Seventh Framework Programme managed by REA - Research Executive Agency (FP7/2007-2013) under grant agreement 312184 PHARMASEA. Jon Andoni Sánchez is supported by a fellowship from Plan Galego de Investigación e Crecemento, Xunta de Galicia, Spain. ; Peer reviewed ; Publisher PDF
L.H.A. thanks the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University for funding this work through the Fast-track Research Funding Program. The authors thank the Captain, crew and scientific party of the 2015-16 'PharmaDeep' cruise on the Spanish Antarctic vessel BIO Hesperides. The cruise activity was supported by the European Union Research Infrastructures project ´EuroFleets 2´ under the 7th Framework Programme of the European Commission (agreement no. 312762). A.J.J. was the awardee of PharmaDeep: New Pharmaceuticals from the deep Antarctic. The authors also would like to thank John Still at ACEMAC for SEM images and the assay providers at Medina for their contribution. ; Peer reviewed ; Postprint
Acknowledgements The research leading to these results has received funding from the following FEDER cofounded-grants. From CDTI and Technological Funds, supported by Ministerio de Economía y Competitividad, AGL2012-40185-CO2-01, AGL2014-58210-R, and Consellería de Cultura, Educación e Ordenación Universitaria, GRC2013-016, and through Axencia Galega de Innovación, Spain, ITC-20133020 SINTOX. From CDTI under ISIP Programme, Spain, IDI-20130304 APTAFOOD. From the European Union's Seventh Framework Programme managed by REA—Research Executive Agency (FP7/2007-2013) under grant agreement 312184 PHARMASEA. We wish to thank the Clínica Losada Arránz, especially Ms. Paula López Arránz for providing the human blood samples for T cells purification. Jon Andoni Sánchez is supported by a fellowship from Plan Galego de Investigación e Crecemento, Xunta de Galicia, Spain. ; Peer reviewed ; Postprint
